Open the mobile version, with barcode scanning
Class II Terminated

Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ.

Why: CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.

Company
NATCO Pharma Limited
Rangareddy, India
Reported
Feb 14, 2024
Recall started
Feb 1, 2024
Ended
Feb 6, 2026
Where sold
Nationwide in the USA
Amount
4260 bottles
Full product description
Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
Lots / codes affected
Lot # 411987 Exp: 05/2025

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.